109 related articles for article (PubMed ID: 2534360)
21. Modeling study of the structure of the macromolecular antitumor antibiotic neocarzinostatin. Origin of the stabilization of the chromophore.
Ishiguro M; Imajo S; Hirama M
J Med Chem; 1991 Aug; 34(8):2366-73. PubMed ID: 1831507
[TBL] [Abstract][Full Text] [Related]
22. Preparation of neocarzinostatin apoprotein mutants and the randomized library on the chromophore-binding cavity.
Tomioka Y; Kisara S; Yoshizawa S; Ozawa M; Suzuki N; Yamaguchi H; Hishinuma T; Mizugaki M; Goto J
Biol Pharm Bull; 2006 May; 29(5):1010-4. PubMed ID: 16651736
[TBL] [Abstract][Full Text] [Related]
23. Enzyme-linked immunosorbent assay of neocarzinostatin chromophore (NCS-chr) by use of a monoclonal antibody against NCS-chr analog.
Mizugaki M; Itoh K; Nakamura H; Ishida N
J Immunoassay; 1996 May; 17(2):133-44. PubMed ID: 8744283
[TBL] [Abstract][Full Text] [Related]
24. Computer modeling analysis for enediyne chromophore-apoprotein complex of macromolecular antitumor antibiotic C-1027.
Okuno Y; Otsuka M; Sugiura Y
J Med Chem; 1994 Jul; 37(15):2266-73. PubMed ID: 8057275
[TBL] [Abstract][Full Text] [Related]
25. Radioimmunoassay of neocarzinostatin, an antitumor protein.
Samy TS; Raso V
Cancer Res; 1976 Dec; 36(12):4378-81. PubMed ID: 63321
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of apo-neocarzinostatin at 0.15-nm resolution.
Teplyakov A; Obmolova G; Wilson K; Kuromizu K
Eur J Biochem; 1993 Apr; 213(2):737-41. PubMed ID: 8477746
[TBL] [Abstract][Full Text] [Related]
27. Neocarzinostatin: effect of modification of side chain amino and carboxyl groups on chemical and biological properties.
Samy TS
Biochemistry; 1977 Dec; 16(25):5573-8. PubMed ID: 144523
[TBL] [Abstract][Full Text] [Related]
28. Two- and three-dimensional proton NMR studies of apo-neocarzinostatin.
Gao XL; Burkhart W
Biochemistry; 1991 Aug; 30(31):7730-9. PubMed ID: 1831044
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous deamidation of a protein antibiotic, neocarzinostatin, at weakly acidic pH. Conversion to a homologous inactive preneocarzinostatin due to change of asparagine 83 to aspartic acid 83 accompanied by conformational and biological alterations.
Maeda H; Kuromizu K
J Biochem; 1977 Jan; 81(1):25-35. PubMed ID: 14934
[TBL] [Abstract][Full Text] [Related]
30. Sequential 1H NMR assignment of the complex of aponeocarzinostatin with ethidium bromide and investigation of protein-drug interactions in the chromophore binding site.
Mohanty S; Sieker LC; Drobny GP
Biochemistry; 1994 Sep; 33(35):10579-90. PubMed ID: 8075058
[TBL] [Abstract][Full Text] [Related]
31. Binding of the nonprotein chromophore of neocarzinostatin to deoxyribonucleic acid.
Povirk LF; Goldberg IH
Biochemistry; 1980 Oct; 19(21):4773-80. PubMed ID: 6448634
[TBL] [Abstract][Full Text] [Related]
32. Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore.
Tanaka T; Fukuda-Ishisaka S; Hirama M; Otani T
J Mol Biol; 2001 May; 309(1):267-83. PubMed ID: 11491295
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanism of novel DNA sugar damage by an antitumour protein antibiotic.
Goldberg IH; Kappen LS; Povirk LF; Chin DH
Drugs Exp Clin Res; 1986; 12(6-7):495-505. PubMed ID: 2943568
[TBL] [Abstract][Full Text] [Related]
34. Is association of labile enediyne chromophore a mutually assured protection for carrier protein?
Kandaswamy J; Hariharan P; Kumar TK; Yu C; Lu TJ; Chin DH
Anal Biochem; 2008 Oct; 381(1):18-26. PubMed ID: 18601891
[TBL] [Abstract][Full Text] [Related]
35. A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic.
Maeda H; Takeshita J; Kanamaru R
Int J Pept Protein Res; 1979 Aug; 14(2):81-7. PubMed ID: 158571
[TBL] [Abstract][Full Text] [Related]
36. Extra-weak chemiluminescence of drugs. IX. Extra-weak chemiluminescence of neocarzinostatin injection.
Edo K; Saito K; Kato M; Akiyama-Murai Y; Sato H; Mizugaki M
Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4603-7. PubMed ID: 2977573
[No Abstract] [Full Text] [Related]
37. Proton NMR studies of apo-neocarzinostatin from Streptomyces carzinostaticus. Sequence-specific assignment and secondary structure.
Adjadj E; Mispelter J; Quiniou E; Dimicoli JL; Favaudon V; Lhoste JM
Eur J Biochem; 1990 Jun; 190(2):263-71. PubMed ID: 2142075
[TBL] [Abstract][Full Text] [Related]
38. Induced formation of a DNA bulge structure by a molecular wedge ligand-postactivated neocarzinostatin chromophore.
Gao X; Stassinopoulos A; Ji J; Kwon Y; Bare S; Goldberg IH
Biochemistry; 2002 Apr; 41(16):5131-43. PubMed ID: 11955061
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of neocarzinostatin, an antitumor protein-chromophore complex.
Kim KH; Kwon BM; Myers AG; Rees DC
Science; 1993 Nov; 262(5136):1042-6. PubMed ID: 8235619
[TBL] [Abstract][Full Text] [Related]
40. The acidic groups of the neocarzinostatin protein play an important role in its biological activity.
Schönlau F; Köhnlein W; Garnett MC
Mol Pharmacol; 1994 Jun; 45(6):1268-72. PubMed ID: 8022419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
